))
A Discussion with Grant Hesser, Portfolio Manager at Social Capital, and Jeremy Sobotta, CEO of Perimeter Medical Imaging AI
Archived series ("Inactive feed" status)
When?
This feed was archived on November 21, 2024 09:12 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 337249288 series 3380517
Content provided by Encode Ideas, L.P., Encode Ideas, and L.P.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Encode Ideas, L.P., Encode Ideas, and L.P. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In January 2022, Social Capital made a C$43.4 million strategic investment in Perimeter Medical Imaging AI (TSX-V: PINK, US: PYNKF) to advance Perimeter's ultra-high-resolution, real-time, imaging technology. In this podcast, we have a conversation with Grant Hesser, Portfolio Manager at Social Capital, and Jeremy Sobotta, CEO of Perimeter Medical, to better understand the attributes of Perimeter's real-time imaging technology, the ongoing commercial rollout of their FDA-cleared S-Series OCT, and development progress of their AI-enabled B-Series OCT for breast conservation surgery. We also dive into the motivation for Social Capital's substantial investment in Perimeter and how their capital will help accelerate Perimeter's commercial plans as well as the company's development plans for breast cancer and beyond.
Disclaimer:
This podcast does not contain financial advice and is for entertainment purposes only. Comments made in the podcast should not be considered an inducement to buy or sell any securities.
7 episodes
Share
